Rosa, N, Feliu, A, Ballbè, M, Alaustre, L, Vilalta, E, Torres, N, Nieva, G, Pla, M, Pinet, C, Raich, A, Mondon, S, Barrio, P, Andreu, M, Suelves, JM, Vilaplana, J, Enríquez, M, Castellano, Y, Guydish, J, Fernández, E, Martínez, C. Quitline nurses' experiences in providing telephone-based smoking cessation help to mental health patients: A mixed methods study. Journal of Psychiatric and Mental Health Nursing. 2024; DOI:10.1111/jpm.13012. PMID:38288784. IF:2.900(Q1/2D).

Efthimiou O., Taipale H., Radua J., Schneider-Thoma J., Pinzón-Espinosa J., Ortuño M., Vinkers C.H., Mittendorfer-Rutz E., Cardoner N., Tanskanen A., Fusar-Poli P., Cipriani A., Vieta E., Leucht S., Tiihonen J., Luykx J.J.. Efficacy and effectiveness of antipsychotics in schizophrenia: network meta-analyses combining evidence from randomised controlled trials and real-world data. LANCET PSYCHIATRY. 2024; 11(2)DOI:10.1016/S2215-0366(23)00366-8. PMID:38215784. IF:24.800(Q1/1D).

Clougher D., Segura A.G., Forte M.F., Mezquida G., Cuesta M.J., Vieta E., Amoretti S., Lobo A., González-Pinto A., Díaz-Caneja C.M., Roldán A., Fico G., De La Serna E., Bergé D., Gassó P., Rodriguez N., Verdolini N., Tortorella A., Menculini G., Ribasés M., Bernardo M., Mas S.. The role of cognitive reserve and clinical symptoms in the association between genetic liability for educational attainment and functioning in first-episode psychosis: A mediation analysis. EUROPEAN PSYCHIATRY. 2024; DOI:10.1192/j.eurpsy.2023.2480. PMID:. IF:(Q/D).

Argyelan, M, Deng, ZD, Ousdal, OT, Oltedal, L, Angulo, B, Baradits, M, Spitzberg, AJ, Kessler, U, Sartorius, A, Dols, A, Narr, KL, Espinoza, R, van Waarde, JA, Tendolkar, I, van Eijndhoven, P, van Wingen, GA, Takamiya, A, Kishimoto, T, Jorgensen, MB, Jorgensen, A, Paulson, OB, Yrondi, A, Péran, P, Soriano-Mas, C, Cardoner, N, Cano, M, van Diermen, L, Schrijvers, D, Belge, JB, Emsell, L, Bouckaert, F, Vandenbulcke, M, Kiebs, M, Hurlemann, R, Mulders, PCR, Redlich, R, Dannlowski, U, Kavakbasi, E, Kritzer, MD, Ellard, KK, Camprodon, JA, Petrides, G, Malhotra, AK, Abbott, CC. Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression (NOV, 10.1038/s41380-023-02318-2, 2023). MOLECULAR PSYCHIATRY. 2023; DOI:10.1038/s41380-023-02358-8. PMID:38052984. IF:9.600(Q1/1D).

Alcantarilla, L, López-Castro, M, Betriu, M, Torres, A, Garcia, C, Solé, E, Gelabert, E, Roca-Lecumberri, A. Risk factors for relapse or recurrence in women with bipolar disorder and recurrent major depressive disorder in the perinatal period: a systematic review. Archives of Womens Mental Health. 2023; 26(6)DOI:10.1007/s00737-023-01370-9. PMID:37718376. IF:3.200(Q2/4D).

Mezquida G., Amoretti S., Bioque M., García-Rizo C., Sánchez-Torres A.M., Pina-Camacho L., Lopez-Pena P., Mané A., Rodriguez-Jimenez R., Corripio I., Sarró S., Ibañez A., Usall J., García-Portilla M.P., Vieta E., Mas S., Cuesta M.J., Parellada M., González-Pinto A., Berrocoso E., Bernardo M.. Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2023; 16(3)DOI:10.1016/j.rpsm.2023.01.004. PMID:37716849. IF:9.200(Q/D).

Vicent-Gil, M, Trujols, J, Serra-Blasco, M, Navarra-Ventura, G, Puigdemont, D, Alemany, C, Crivillés, S, de Diego-Adeliño, J, Cardoner, N, Portella, MJ. If you feel you can't, you won't: the role of subjective and objective cognitive competence on psychosocial functioning in depression. EUROPEAN PSYCHIATRY. 2023; 66(1)DOI:10.1192/j.eurpsy.2023.2454. PMID:37855104. IF:7.200(Q1/1D).

Contreras-Rodriguez, O, Reales-Moreno, M, Fernandez-Barres, S, Cimpean, A, Arnoriaga-Rodriguez, M, Puig, J, Biarnes, C, Motger-Alberti, A, Cano, M, Fernandez-Real, JM. Consumption of ultra-processed foods is associated with depression, mesocorticolimbic volume, and inflammation. JOURNAL OF AFFECTIVE DISORDERS. 2023; 335DOI:10.1016/j.jad.2023.05.009. PMID:37207947. IF:4.900(Q1/2D).

Fagiolini A., Cardoner N., Pirildar S., Ittsakul P., Ng B., Duailibi K., El Hindy N.. Moving from serotonin to serotonin-norepinephrine enhancement with increasing venlafaxine dose: clinical implications and strategies for a successful outcome in major depressive disorder. EXPERT OPINION ON PHARMACOTHERAPY. 2023; 24(15)DOI:10.1080/14656566.2023.2242264. PMID:37501324. IF:2.500(Q3/6D).

Mateo-Canedo, C, Sanabria-Mazo, JP, Comendador, L, Rojas, JS, Carmona, M, Crespo-Puig, N, Anyosa, F, Selva, C, Feliu-Soler, A, Cardoner, N, Deus, J, Luciano, JV, Mendez-Ulrich, JL, Sanz, A. Predictive factors of hesitancy to vaccination against SARS-CoV-2 virus in young adults in Spain: Results from the PSY-COVID study. Vaccine: X. 2023; 14DOI:10.1016/j.jvacx.2023.100301. PMID:37091731. IF:(Q/D).

Grasa E., Corripio I., Peris-Baquero O., Roldán A., Selma J., Osma J.. Opening Treatment Windows for Treatment-Resistant Schizophrenia: Improving Emotion Regulation Strategies Using the Unified Protocol in a Case Study in Spain. Clinical Case Studies. 2023; DOI:10.1177/15346501231190912. PMID:. IF:0.800(Q4/9D).

Cano, M, Lee, E, Polanco, C, Barbour, T, Ellard, KK, Andreou, B, Uribe, S, Henry, ME, Seiner, S, Cardoner, N, Soriano-Mas, C, Camprodon, JA. Brain volumetric correlates of electroconvulsive therapy versus transcranial magnetic stimulation for treatment-resistant depression. JOURNAL OF AFFECTIVE DISORDERS. 2023; 333DOI:10.1016/j.jad.2023.03.093. PMID:37024015. IF:4.900(Q1/2D).

Oteo-Álvaro Á., García C.G., Sánchez A.I., Santamaria C.A., de Diego-Adeliño J.. Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS). OSTEOPOROSIS INTERNATIONAL. 2023; 34(10)DOI:10.1007/s00198-023-06838-z. PMID:37405407. IF:4.200(Q1/3D).

Goodman-Casanova J.M., Cuesta-Lozano D., Alupoaei C., Bello, EMG, Herrera-Imbroda J., Mayoral-Cleries F., Guzman-Parra J.. Psychometric validation of the 15-item Questionnaire about the Process of Recovery in Spain (QPR-15-SP). Frontiers in Psychology. 2023; 14DOI:10.3389/fpsyg.2023.1178341. PMID:37484089. IF:2.600(Q2/3D).

Arca, G, Nunez, C, Stephan-Otto, C, Arnaez, J, Agut, T, Cordeiro, M, Boronat, N, Lubian-Lopez, S, Benavente-Fernandez, I, Valverde, E, Garcia-Alix, A. Massive Neonatal Arterial Ischemic Stroke. PEDIATRIC NEUROLOGY. 2023; 144DOI:10.1016/j.pediatrneurol.2023.03.013. PMID:37087915. IF:3.200(Q1/2D).

Segura, AG, Mane, A, Prohens, L, Rodriguez, N, Mezquida, G, Cuesta, MJ, Vieta, E, Amoretti, S, Lobo, A, Gonzalez-Pinto, A, Diaz-Caneja, CM, Bejarano, AR, Jimenez, E, Baeza, I, Legido, T, Saiz-Ruiz, J, Bernardo, M, Mas, S. Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort. PSYCHIATRY RESEARCH. 2023; 325DOI:10.1016/j.psychres.2023.115249. PMID:37178502. IF:4.200(Q1/2D).

Serra-Navarro M., Amoretti S., Verdolini N., Forte M.F., Sánchez-Torres A.M., Vieta E., Clougher D., Lobo A., González-Pinto A., Panadero R., Roldán A., Carvalho A.F., de la Serna E., Toll A., Ramos-Quiroga J.A., Torrent C., Cuesta M.J., Bernardo M., PEPs Grp. Influence of clinical and neurocognitive factors in psychosocial functioning after a first episode non-affective psychosis: differences between males and females (vol 13, 982583, 2022). Frontiers in Psychiatry. 2023; 14DOI:10.3389/fpsyt.2023.1200313. PMID:37383614. IF:3.200(Q2/4D).

Pascual, JC, Arias, L, Soler, J. Pharmacological Management of Borderline Personality Disorder and Common Comorbidities. CNS DRUGS. 2023; 37(6)DOI:10.1007/s40263-023-01015-6. PMID:37256484. IF:7.400(Q1/1D).

Fraguas D., Almenta Gallego D., Arques-Egea S., Gómez-Revuelta M., Sánchez-Lafuente C.G., Hernández Huerta D., Núñez Arias D., Oda Plasencia-García B., Parro Torres C., Romero-Guillena S.L., Ros Cucurul E., Alamo C.. Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practice. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE. 2023; 27(1)DOI:10.1080/13651501.2022.2064308. PMID:35792729. IF:2.900(Q2/4D).

Valli, I, Segura, AG, Verdolini, N, Garcia-Rizo, C, Berge, D, Baeza, I, Cuesta, MJ, Gonzalez-Pinto, A, Lobo, A, Martinez-Aran, A, Mezquida, G, Pina-Camacho, L, Bejarano, AR, Mas, S, McGuire, P, Bernardo, M, Vieta, E, PEPs Grp. Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis. ACTA PSYCHIATRICA SCANDINAVICA. 2023; 148(1)DOI:10.1111/acps.13546. PMID:36912272. IF:5.300(Q1/2D).